Traumatic Optic Neuropathy
7
1
1
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
14%
1 trials in Phase 3/4
50%
1 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (7)
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for NAION
Traumatic Optic Neuropathy Treatment Trial 2
The Neuroprotective Effect of PEG-GCSF in the Traumatic Optic Neuropathy
Diffusion Weighted Magnetic Resonance Imaging and the Optic Nerve Neuropathy.
Targeted Shortwave Diathermy Combined With Perceptual Training for Patients With Severe Traumatic Optic Neuropathy
Traumatic Optic Neuropathy Treatment Trial (TONTT)
Surgery for Traumatic Optic Neuropathy